Longevity Biotech And Epigenetic Reprogramming Market Trends And Growth Drivers Point To Strong Future Potential
Longevity Biotech And Epigenetic Reprogramming market size was valued at $27.11 billion in 2026, projected to reach $44.05 billion by 2030 at a 12.9% CAGR. Key players: Altos Labs Inc., Retro Biosciences Inc., NewLimit Inc.

